• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:彭应珍,孙惠,赵静玉,周倩,吴芳芳,张宁.基于代谢组学和网络药理学探讨鸡骨草抗胆汁淤积的作用机制[J].药学研究,2026,45(1):9-16,62[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3048次   下载 856次 本文二维码信息
码上扫一扫!
基于代谢组学和网络药理学探讨鸡骨草抗胆汁淤积的作用机制
彭应珍1,孙惠1,赵静玉1,周倩1,吴芳芳2,张宁1
字体:加大+|默认|缩小-
(1.黑龙江中医药大学药学院,黑龙江 哈尔滨 150040;2.广西中医药大学中药壮瑶药创新药物教育部工程研究中心,广西 南宁 530200)
摘要:
目的 基于药效学、代谢组学及网络药理学探究鸡骨草醇提物对α-萘异硫氰酸酯(ANIT)诱导的胆汁淤积小鼠模型的治疗作用及其潜在机制。方法 将24只雄性C57BL/6J小鼠随机分为3组:正常组(Con)、模型组(Mod)和鸡骨草组(AC),采用灌胃给与ANIT油溶液复制胆汁淤积模型,利用全自动生化分析仪对小鼠血清中天门冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、碱性磷酸酶(ALP)、总胆红素(TBIL)和总胆汁酸(TBA)水平进行测定;通过酶联免疫吸附法(ELISA)对小鼠肝组织中肿瘤坏死因子α(TNF-α)和白细胞介素-6(IL-6)的表达水平进行检测;运用苏木素-伊红(HE)染色法对小鼠肝组织进行病理切片观察。非靶向组学检测各组小鼠肝脏差异代谢产物,网络药理学预测鸡骨草抗胆汁淤积的潜在靶点与通路。结果 与Con组比,Mod组小鼠的血清AST、ALT、ALP、TBIL、TBA水平显著增高(P<0.05、0.01、0.001),肝组织TNF-α和IL-6水平增高(P<0.01);HE染色显示小鼠肝脏结缔组织疏松,大片炎性细胞浸润,AC组可有效逆转上述指标;肝脏代谢组学筛选出牛磺酸、谷胱甘肽、牛磺胆酸等27个差异代谢物,主要富集到牛磺酸和次牛磺酸代谢、初级胆汁酸生物合成、谷胱甘肽代谢、嘌呤代谢4条代谢通路;网络药理学预测到鸡骨草21个活性成分,包括β-谷甾醇、大黄素、豆甾醇、相思子碱等;鸡骨草活性成分靶点与胆汁淤积的交集靶点有119个,PPI网络筛选出20个核心靶点,涉及化学致癌-受体活化、胆汁分泌、化学致癌-DNA加合物等信号通路。结论 鸡骨草对胆汁淤积小鼠有明显的保护作用,这种作用可能与调节胆汁酸代谢及谷胱甘肽代谢有关。
关键词:  鸡骨草  胆汁淤积  网络药理学  非靶向代谢组学
DOI:10.13506/j.cnki.jpr.2026.01.002
基金项目:国家自然科学基金区域创新发展联合基金重点支持项目(No.U23A20521);国家自然科学基金地区基金项目(No.82360767)
出版日期:2026-01-26
The mechanism of Abrus cantoniensis against cholestasis based on metabolomics and network pharmacology
PENG Yingzhen1,SUN Hui1,ZHANG Jingyu1,ZHOU Qian1,WU Fangfang2,ZHANG Ning1
(1.Heilongjiang University of Traditional Chinese medicine, College of Pharmacy, Harbin 150040, China; 2.Guangxi University of Chinese Medicine, Engineering research center of Zhuangyao Medicine, Ministry of Education, Nanning 530200, China)
Abstract:
Objective To explore the therapeutic effect and underlying mechanism of Abrus cantoniensis ethanol extract on ANIT-induced cholestasis mouse model based on pharmacodynamics, metabolomics and network pharmacology.Methods Twenty-four male C57BL/6J mice were randomly divided into three groups: normal group (Con) , model group (Mod) and Abrus cantoniensis group (AC) , the levels of aspartate aminotransferase (AST) , alanine aminotransferase (Alt) , alkaline phosphatase acid (ALP) , total bilirubin (TBIL) and total bile acid (TBA) in serum of mice were determined by automatic biochemical analyzer;the expression levels of tumor necrosis factor (TNF-α) and IL-6(IL-6) in the liver tissues of mice were detected by ELISA Hematoxylin and eosin (HE) staining was used to observe the pathological sections of liver tissue in mice. UNTARGETED OMICS was used to detect the differential metabolites in the liver of each group of mice, and network pharmacology was used to predict the potential targets and pathways of Abrus cantoniensis against cholestasis.Results Compared with Con group, the levels of serum AST, ALT, ALP, TBIL and TBA in Mod group were significantly increased (P<0.05,0.01,0.001) , and the levels of TNF-α and IL-6 in liver tissue were increased (P<0.01); HE staining showed that the connective tissue of the liver was loose and a large area of inflammatory cells infiltrated 27 differential metabolites such as taurine, glutathione and taurocholic acid were screened out by liver metabolomics, it was mainly enriched in four metabolic pathways: Taurine and hypotaurine metabolism, primary bile acid biosynthesis, glutathione metabolism and purine metabolism;Network pharmacology predicted 21 active components of Abrus cantoniensis, including β-sitosterol, emodin, stigmasterol, abrin, etc. There were 119 intersecting targets between the active components of abrus cantoniensis and cholestasis, and 20 core targets were screened out by PPI network, it involves chemical carcinogenesis-receptor activation, bile secretion, chemical carcinogenesis-DNA adducts and other signaling pathways. Conclusion Abrus cantoniensis has obvious protective effect on cholestasis mice, which may be related to the regulation of bile acid metabolism and glutathione metabolism.
Key words:  Abrus cantoniensis  Cholestasis  Network pharmacology  Untargeted metabolomics
今日访问量:2271    总访问量:55338612
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司